News

ZAS Corporation Participates in Anesthesia Day 2025, Strengthening Commitment to Patient Care

Leave a Comment / News / By

https://www.facebook.com/share/v/1a9fjSn8TH ZAS Corporation was privileged to participate in the Anesthesia Day 2025 Celebration, reaffirming its commitment to advancing anesthesia practice in Bangladesh. The program provided a dynamic platform for connecting with distinguished anesthesiologists and healthcare leaders, fostering thoughtful exchanges of knowledge and experiences. These interactions reinforced ZAS Corporation’s dedication to enhancing patient safety, improving access […]

ZAS Corporation Participates in Anesthesia Day 2025, Strengthening Commitment to Patient Care Read More »

ZAS Corporation Launches DECA® Surgical Glove Series, A New Era in Surgical Excellence

Leave a Comment / 2025, News / By

ZAS Corporation proudly announces the official launch of its DECA® series of sterile surgical gloves, marking a significant milestone in advancing surgical safety, comfort, and skin protection. The launch event, themed “Launch & Lead with DECA”, was held at a picturesque resort and brought together our dedicated team, esteemed partners, and industry leaders in a

ZAS Corporation Launches DECA® Surgical Glove Series, A New Era in Surgical Excellence Read More »

ZAS Corporation Strengthens Partnership with Celltrion Korea

Leave a Comment / 2025, News / By

ZAS Corporation recently held a strategic business overview meeting with its esteemed global partner, Celltrion from Korea. The session focused on sharing insights, aligning future plans, and exploring new opportunities for growth. Both teams discussed the current business landscape and reaffirmed their commitment to delivering innovative solutions together. This collaboration continues to reinforce ZAS Corporation’s

ZAS Corporation Strengthens Partnership with Celltrion Korea Read More »

ZAS Corporation & BIRDEM General Hospital Introduce Advanced Biosimilar Therapies in Rheumatology Care

Leave a Comment / 2025, News / By

ZAS Corporation is proud to collaborate with the Rheumatology Department of BIRDEM General Hospital to introduce three world-class biosimilar therapies from Celltrion Healthcare, Korea—Yuflyma® (adalimumab), Truxima® (rituximab), and Remsima® (infliximab).The initiative was formally marked at a recent CME event, where Dr. Sabrina Yesmin, Associate Professor & Head of the Rheumatology Department, shared her expert insights

ZAS Corporation & BIRDEM General Hospital Introduce Advanced Biosimilar Therapies in Rheumatology Care Read More »

ZAS Corporation Hosts CME on Advancing Psoriasis Care with Adalimumab

Leave a Comment / 2025, News / By

ZAS Corporation’s Dermatology Division recently organized a Continuing Medical Education (CME) program at BIDSA, focusing on “The Role of Adalimumab in Psoriasis Management.” The session brought together leading dermatology experts to discuss updated clinical guidelines, recent research findings, and practical experiences in using adalimumab to manage moderate to severe psoriasis. Participants engaged in an interactive

ZAS Corporation Hosts CME on Advancing Psoriasis Care with Adalimumab Read More »

ZAS Corporation Empowers ICU Nurses with Noradrenaline Best Practices Training

Leave a Comment / 2025, News / By

ZAS Corporation recently organized a series of training sessions across multiple hospitals, engaging ICU nurses on the safe and effective use of noradrenaline in critical care settings. The program focused on practical guidance, updated protocols, and real-world application to support better patient outcomes. Through these interactive sessions, ZAS continues its commitment to enhancing clinical excellence

ZAS Corporation Empowers ICU Nurses with Noradrenaline Best Practices Training Read More »

ZAS Onco & MOSB Host Scientific Seminar on Recent Advances in Bevacizumab Therapy

Leave a Comment / News / By

ZAS Onco, a division of ZAS Corporation Ltd., in collaboration with the Medical Oncology Society of Bangladesh (MOSB), recently organized a scientific seminar titled “Recent Advances in Bevacizumab Therapy: Expanding the Horizon.” The event served as a valuable platform for oncologists and cancer care professionals to discuss the evolving clinical applications and therapeutic advancements of

ZAS Onco & MOSB Host Scientific Seminar on Recent Advances in Bevacizumab Therapy Read More »

ZAS Corporation Joins Aqvida GmbH in Celebrating 20 Years of Oncology Excellence in Germany

Leave a Comment / News / By

Hamburg & Dassow, Germany | 14–17 May 2025ZAS Corporation proudly participated in the 20th anniversary celebration of Aqvida GmbH, one of Europe’s most respected oncology pharmaceutical companies. The global event, held in Hamburg and Dassow, brought together healthcare leaders and partners from over 35 countries to commemorate two decades of innovation and excellence in cancer

ZAS Corporation Joins Aqvida GmbH in Celebrating 20 Years of Oncology Excellence in Germany Read More »

ZAS Corporation and Canyon Introduce Microwave Ablation for Fibroids for the First Time in Bangladesh

Leave a Comment / News / By

In a groundbreaking advancement for women’s healthcare in Bangladesh, ZAS Corporation, in collaboration with Canyon, has successfully launched Microwave Ablation for Fibroids for the very first time in the country. This innovative, minimally invasive procedure represents a new standard in fibroid treatment — offering faster recovery, reduced complications, and improved patient outcomes. The official launch

ZAS Corporation and Canyon Introduce Microwave Ablation for Fibroids for the First Time in Bangladesh Read More »

ZAS Ophthalmic Successfully Launches Timo-COMOD and Pollival with Leading Ophthalmologists

Leave a Comment / News / By

ZAS Ophthalmic, a concern of ZAS Group, proudly launched two innovative ophthalmic products — Timo-COMOD and Pollival — in the presence of distinguished ophthalmologists. This special event marked a significant milestone for ZAS Ophthalmic as it continues its commitment to bringing advanced, patient-friendly eye care solutions to Bangladesh. The launching program was held with the

ZAS Ophthalmic Successfully Launches Timo-COMOD and Pollival with Leading Ophthalmologists Read More »

CONNECT
CONNECT
Scroll to Top